KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $64.4 billion.

  • Novartis Ag's Total Liabilities rose 1080.52% to $64.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $64.4 billion, marking a year-over-year increase of 1080.52%. This contributed to the annual value of $64.4 billion for FY2025, which is 1080.52% up from last year.
  • Per Novartis Ag's latest filing, its Total Liabilities stood at $64.4 billion for Q4 2025, which was up 1080.52% from $62.5 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Total Liabilities ranged from a high of $74.5 billion in Q3 2023 and a low of $53.2 billion during Q4 2023
  • Its 5-year average for Total Liabilities is $61.7 billion, with a median of $60.8 billion in 2023.
  • In the last 5 years, Novartis Ag's Total Liabilities surged by 2933.33% in 2023 and then tumbled by 1929.97% in 2024.
  • Novartis Ag's Total Liabilities (Quarter) stood at $64.0 billion in 2021, then fell by 9.29% to $58.0 billion in 2022, then decreased by 8.33% to $53.2 billion in 2023, then increased by 9.26% to $58.1 billion in 2024, then grew by 10.81% to $64.4 billion in 2025.
  • Its last three reported values are $64.4 billion in Q4 2025, $62.5 billion for Q3 2025, and $62.3 billion during Q2 2025.